Publications

Recent advances in CDC42 subfamily inhibition and therapeutic potential

 9
Recent advances in CDC42 subfamily inhibition and therapeutic potential

Tags:

Previous Article

Metabolic dysfunction from heat stress via skin-hypothalamus axis

Next Article

Inhibiting CDC42 subfamily to treat diseases

Related Posts

LGR5: from stem cell marker to therapeutic target

LGR5: from stem cell marker to therapeutic target

 46

Immune signaling and function in neurodegeneration

Immune signaling and function in neurodegeneration

 79

Lysosomal “TRAP”: a neotype modality for clearance of viruses and variants

Lysosomal “TRAP”: a neotype modality for clearance of v...

 169